Does DABIGATRAN ETEXILATE Cause Activated partial thromboplastin time prolonged? 264 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Activated partial thromboplastin time prolonged have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.7% of all adverse event reports for DABIGATRAN ETEXILATE.
264
Reports of Activated partial thromboplastin time prolonged with DABIGATRAN ETEXILATE
0.7%
of all DABIGATRAN ETEXILATE reports
45
Deaths
182
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From DABIGATRAN ETEXILATE?
Of the 264 reports, 45 (17.0%) resulted in death, 182 (68.9%) required hospitalization, and 40 (15.2%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
ASPIRIN (87)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB